Official GMP audit in Japan

2012-07-18

　　The Japan Medicines and Medical Machinery Agency (PMDA) conducted an on-site GMP compliance inspection of our company's irinotecan hydrochloride from May 18 to May 20, 2010. One month later, we received formal notification from PMDA that the production and inspection of Sichuan Xieli Pharmaceutical's Illitacan Hydrochloride API met GMP requirements

2024-11-26

Xieli Pharmaceutical Participates in Pharmtech & Ingredients...

2024-11-18

Sichuan Xieli Pharmaceutical Co., Ltd. 2025 Global Exhibitio...

2024-11-02

Sichuan Xieli Pharmaceutical Co., Ltd. Making a Stunning App...

Composing the International Chapter of the Chinese Pharmaceutical Industry

2024-10-16

Deepening Global Markets: Sichuan Xieli Pharmaceutical Shine...

2024-09-09

Focusing on Global Health, Quality& Innovation Soar Together...

Sichuan Xieli Pharmaceutical Achieves New Heights in Exploring the International Market at CPHI Korea